Register now for this free live demo Thursday, September 17 @ 1:00pm Eastern. See Aimee, Find-A-Code's AI medical coding expert.
You will be amazed at the coding questions she can answer for you. Here are some examples:
What modifiers are commonly used with this CPT code?
What chaned for this code in 2025?
Explain this CPT code in plain language.
How should I code chronic hear failure?
Is J44.1 part of any HCC's'?
What are the clinical indicators for acute kidney failure?
Why Find-A-Code?
NEW Aimee AI expert makes you a faster, better coder
Complete Code Sets: CPT®, ICD-10-CM, HCPCS and more
The Easiest, Fastest, and Most Accurate NCCI Validation
Complete NCD/LCD Policies
All The Features You Need
AHA Coding Clinic® integration
RVUs with facility factors
UCR fees by location
Commercial payer policies
Common Language Descriptions (CLDs)
Many, many more!
AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2021 Quarter 4; ICD-10-CM New/Revised Codes
Hereditary Alpha Tryptasemia
Subcategory D89.4 , Mast cell activation syndrome and related disorders, has been expanded with the creation of code D89.44 , Hereditary alpha tryptasemia . Hereditary alpha tryptasemia (HαT) is a genetic trait that is characterized by an elevated basal serum tryptase, a mast cell mediator, and increased copies of the gene TPSAB1. The increase of tryptase and copies of TPSAB1 are associated with multiple complaints, such as skin flushing, pruritus, dysautonomia (dysfunction of the autonomic nervous system), chronic pain, and connective tissue abnormalities. Those with hereditary alpha tryptasemia have an increased risk of severe allergic reactions to stinging...
Note: The following article synopsis was NOT provided by the AHA. It was created by Find-A-Code/innoviHealth.
Article Overview
This brief coding update covers the addition of a diagnosis code for hereditary alpha tryptasemia within the ICD-10-CM mast cell activation syndrome and related disorders category. It is relevant to coders, clinical documentation teams, and anyone tracking mast cell-related conditions, genetic traits, and related patient outcomes. The article provides a high-level clinical overview of the condition and explains the reporting context for the new code.
Why This Topic Matters
This update matters because it introduces a new diagnosis category for a specific hereditary mast cell-related trait, supporting more accurate documentation, data tracking, and outcome analysis.
What You Will Learn
How hereditary alpha tryptasemia is positioned within ICD-10-CM classification
What broad clinical features are associated with the condition
Why the new diagnosis code is important for tracking and reporting
How the update fits into mast cell activation syndrome and related disorders